Neurocognitive and Psychosocial Outcomes in Survivors of Childhood Leukemia With Down Syndrome NCT02859389 Leukemia
Down Syndrome
- St. Jude Children's Research Hospital View ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 NCT03286634 Down Syndrome
Acute Lymphobla...
Childhood Cance...
Daunorubicin
Prednisolone
Vincristine
Epirubicin
E-coli L-aspara...
6-Mercaptopurin...
Methotrexate
Hydrocortisone
Cytarabine
Cyclophosphamid...
0 Years - 20 Years National Hospital Organization Nagoya Medical Center View Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma NCT01190930 Acute Lymphobla...
Adult B Lymphob...
Ann Arbor Stage...
Ann Arbor Stage...
Childhood B Acu...
Childhood B Acu...
Childhood B Lym...
Down Syndrome
Hypodiploid B A...
Philadelphia Ch...
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Quality-of-Life...
Questionnaire A...
Thioguanine
Vincristine Sul...
1 Year - 30 Years Children's Oncology Group View Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome NCT02521493 Acute Myeloid L...
Down Syndrome
Myelodysplastic...
Myeloid Leukemi...
Myeloproliferat...
Asparaginase
Asparaginase Er...
Cytarabine
Daunorubicin Hy...
Etoposide
Laboratory Biom...
Mitoxantrone Hy...
Thioguanine
91 Days - 3 Years Children's Oncology Group View A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia NCT03914625 B Acute Lymphob...
B Lymphoblastic...
Down Syndrome
Asparaginase Er...
Blinatumomab
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Mercaptopurine ...
Methotrexate
Pegaspargase
Prednisolone
Prednisone
Radiation Thera...
Radiation Thera...
Thioguanine
Vincristine Sul...
365 Days - 31 Years National Cancer Institute (NCI) View Parent and Infant Inter(X)Action Intervention (PIXI) NCT03836300 Fragile X Syndr...
Angelman Syndro...
Prader-Willi Sy...
Dup15Q Syndrome
Duchenne Muscul...
Phelan-McDermid...
Rett Syndrome
Smith Magenis S...
Williams Syndro...
Turner Syndrome
Klinefelter Syn...
Chromosome 22q1...
Tuberous Sclero...
Down Syndrome
Parent-Infant I...
- 99 Years RTI International View A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia NCT03914625 B Acute Lymphob...
B Lymphoblastic...
Down Syndrome
Asparaginase Er...
Blinatumomab
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Mercaptopurine ...
Methotrexate
Pegaspargase
Prednisolone
Prednisone
Radiation Thera...
Radiation Thera...
Thioguanine
Vincristine Sul...
365 Days - 31 Years National Cancer Institute (NCI) View ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 NCT03286634 Down Syndrome
Acute Lymphobla...
Childhood Cance...
Daunorubicin
Prednisolone
Vincristine
Epirubicin
E-coli L-aspara...
6-Mercaptopurin...
Methotrexate
Hydrocortisone
Cytarabine
Cyclophosphamid...
0 Years - 20 Years National Hospital Organization Nagoya Medical Center View A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL) NCT04546399 Down Syndrome
Recurrent B Acu...
3-Dimensional C...
Blinatumomab
Cyclophosphamid...
Cytarabine
Dexamethasone
Etoposide
Hydrocortisone ...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Nivolumab
Pegaspargase
Thioguanine
Vincristine Sul...
1 Year - 30 Years National Cancer Institute (NCI) View Neurocognitive and Psychosocial Outcomes in Survivors of Childhood Leukemia With Down Syndrome NCT02859389 Leukemia
Down Syndrome
- St. Jude Children's Research Hospital View A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia NCT05702645 B Acute Lymphob...
Down Syndrome
Myeloid Leukemi...
Biospecimen Col...
Clinical Evalua...
Questionnaire A...
Survey Administ...
6 Years - 39 Years Children's Oncology Group View